Rezultati - Nicholas Voss
- Showing 1 - 5 results of 5
-
1
-
2
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988 od Andreas Lohri, Michael Barnett, RN Fairey, SE O’Reilly, GL Phillips, DE Reece, Nicholas Voss, Connors Jm
Izdano 1991Artigo -
3
-
4
Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma* od Richard Doocey, Cynthia L. Toze, Joseph M. Connors, Thomas J. Nevill, Randy D. Gascoyne, Michael J. Barnett, Donna L. Forrest, Donna E. Hogge, Julye C. Lavoie, Stephen H. Nantel, John D. Shepherd, Heather J. Sutherland, Nicholas Voss, Clayton A. Smith, Kevin Song
Izdano 2005Artigo -
5
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouve... od Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips, Donna Reece, Michael J. Barnett, Donna L. Forrest, Randy D. Gascoyne, Donna E. Hogge, Stephen H. Nantel, John D. Shepherd, Clayton A. Smith, Kevin Song, Heather J. Sutherland, Cynthia L. Toze, Nicholas Voss, Thomas J. Nevill
Izdano 2005Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Lymphoma
Oncology
Chemotherapy
Surgery
Transplantation
Astrobiology
Biology
Cancer research
Chemotherapy regimen
Paleontology
Refractory (planetary science)
Stage (stratigraphy)
ABVD
Aggressive lymphoma
Autologous stem-cell transplantation
CHOP
Cohort
Cyclophosphamide
Dacarbazine
Diffuse large B-cell lymphoma
Genetics
Geology
Haematopoiesis
Hematology
Hematopoietic stem cell transplantation
Histology
Hodgkin lymphoma
International Prognostic Index